Male, V. SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nat. Rev. Immunol. 22, 277–282 (2022).
Article CAS PubMed PubMed Central Google Scholar
Blakeway, H. et al. COVID-19 vaccination during pregnancy: coverage and safety. Am. J. Obstet. Gynecol. 226, 236.e231–236.e214 (2022).
ACOG. COVID-19 Vaccines and Pregnancy: Conversation Guide. https://www.acog.org/covid-19/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians (2022).
Halasa, N. B. et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months—17 states, July 2021–January 2022. MMWR Morb. Mortal. Wkly Rep. 71, 264–270 (2022).
Article CAS PubMed PubMed Central Google Scholar
Pratama, N. R. et al. mRNA Covid-19 vaccines in pregnancy: a systematic review. PLoS One 17, e0261350 (2022).
Article CAS PubMed PubMed Central Google Scholar
Jorgensen, S. C. J. et al. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ 380, e074035 (2023).
Guedalia, J. et al. Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel. Nat. Commun. 15, 2846 (2024).
Article CAS PubMed PubMed Central Google Scholar
CDC. Trends in United States COVID-19 Hospitalizations, Deaths, Emergency Department (ED) Visits, and Test Positivity by Geographic Area. https://covid.cdc.gov/covid-data-tracker/#trends_dailycases (2024).
Adhikari, E. H. et al. COVID-19 cases and disease severity in pregnancy and neonatal positivity associated with delta (B.1.617.2) and omicron (B.1.1.529) variant predominance. JAMA 327, 1500–1502 (2022).
Article CAS PubMed PubMed Central Google Scholar
Hamid, S. et al. COVID-19-associated hospitalizations among U.S. infants aged <6 Months—COVID-NET, 13 states, June 2021–August 2022. MMWR Morb. Mortal. Wkly Rep. 71, 1442–1448 (2022).
Article PubMed PubMed Central Google Scholar
Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120–124 (2020).
Article CAS PubMed Google Scholar
Du, L. et al. The spike protein of SARS-CoV— a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226–236 (2009).
Article CAS PubMed PubMed Central Google Scholar
Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657–663 (2022).
Article CAS PubMed Google Scholar
Sievers, B. L. et al. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Sci. Transl. Med. 14, eabn7842 (2022).
Article CAS PubMed Google Scholar
Chan, C. M. et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J. Clin. Virol. 45, 54–60 (2009).
Article CAS PubMed PubMed Central Google Scholar
Payne, S. In Viruses (ed Susan Payne) 61–71 (Academic Press, 2017).
Clarke, K. E. N. et al. Seroprevalence of infection-induced SARS-CoV-2 antibodies—United States, September 2021–February 2022. MMWR Morb. Mortal. Wkly Rep. 71, 606–608 (2022).
Article CAS PubMed PubMed Central Google Scholar
Schuh, A. J. et al. SARS-CoV-2 convalescent sera binding and neutralizing antibody concentrations compared with COVID-19 vaccine efficacy estimates against symptomatic infection. Microbiol Spectr. 10, e0124722 (2022).
Ng, D. L. et al. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nature. Communications 11, 4698 (2020).
Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020).
Article CAS PubMed Google Scholar
Golan, Y. et al. COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother–infant dyads. Front Immunol. 12, 777103 (2021).
Article CAS PubMed PubMed Central Google Scholar
Golan, Y. et al. Milk antibody response after 3(rd) COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection. iScience 26, 107767 (2023).
Article CAS PubMed PubMed Central Google Scholar
Fu, W. et al. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J. Gynaecol. Obstet. 156, 406–417 (2022).
Article CAS PubMed Google Scholar
Valcarce, V. et al. Detection of SARS-CoV-2-specific IgA in the human milk of COVID-19 vaccinated lactating health care workers. Breastfeed. Med. 16, 1004–1009 (2021).
Article CAS PubMed Google Scholar
Richard, R. M. et al. Breast milk conferred immunity to infants against COVID-19. Cureus 15, e42075 (2023).
PubMed PubMed Central Google Scholar
Sabharwal, V. et al. Comparison of anti-SARS-CoV-2-specific antibody signatures in maternal and infant blood after COVID-19 infection versus COVID-19 vaccination during pregnancy. Am. J. Perinatol. 41, e2970–e2977(2023).
Zelini, P. et al. Impact of SARS-CoV-2 infection during pregnancy and persistence of antibody response. N. Microbiol. 45, 181–189 (2022).
Rick, A. M. et al. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies. PLoS One 18, e0287103 (2023).
Article CAS PubMed PubMed Central Google Scholar
Dude, C. M. et al. Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancy. Int J. Gynaecol. Obstet. 162, 154–162 (2023).
Article CAS PubMed Google Scholar
Sano, K. et al. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat. Commun. 13, 5135 (2022).
Article CAS PubMed PubMed Central Google Scholar
Crotty, S. Hybrid immunity. Science 372, 1392–1393 (2021).
Lucot-Royer, L. et al. Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection. Sci. Rep. 14, 3458 (2024).
Article CAS PubMed PubMed Central Google Scholar
Prabhu, M. et al. Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons. Am. J. Obstet. Gynecol. MFM 5, 100796 (2023).
Article CAS PubMed Google Scholar
Conti, M. G. et al. Immune response of neonates born to mothers infected with SARS-CoV-2. JAMA Netw. Open 4, e2132563 (2021).
Article PubMed PubMed Central Google Scholar
Hookham, L. et al. Seroepidemiology of SARS-CoV-2
Comments (0)